Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacokinetics and Safety of Vortioxetine in the Chinese Population
Miao Jia, Gang Wang, Jie Hou, et al.
Advances in Therapy (2019) Vol. 36, Iss. 11, pp. 3134-3146
Open Access | Times Cited: 9

Showing 9 citing articles:

Mechanisms of NMDA receptor inhibition by vortioxetine – comparison with fluoxetine
Arseniy S. Zhigulin, Oleg I. Barygin
European Journal of Pharmacology (2025), pp. 177460-177460
Closed Access
Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update
Daniela Adamo, Elena Calabria, Noemi Coppola, et al.
Therapeutic Advances in Psychopharmacology (2021) Vol. 11
Open Access | Times Cited: 20
The Role of Vortioxetine in the Treatment of Depressive Symptoms in General Hospital Psychiatry: A Case-Series and PRISMA-Compliant Systematic Review of the Literature
Francesco Weiss, Bruno Pacciardi, Giulia D’Alessandro, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 531-531
Open Access | Times Cited: 2
Inhibitory Effectiveness in Delayed-Rectifier Potassium Current Caused by Vortioxetine, Known to Be a Novel Antidepressant
Hung‐Tsung Hsiao, Jeffrey Chi-Fei Wang, Sheng‐Nan Wu
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1318-1318
Open Access | Times Cited: 11
A Taiwanese study on real-world evidence with vortioxetine in patients with major depression in Asia (TREVIDA)
Yen Kuang Yang, Cheng-Sheng Chen, Chia-Fen Tsai, et al.
Current Medical Research and Opinion (2021) Vol. 37, Iss. 12, pp. 2163-2173
Closed Access | Times Cited: 14
Toxicity of waterborne vortioxetine, a new antidepressant, in non-target aquatic organisms: From wonder to concern drugs?
Xiangsheng Hong, Le Zhang, Jinmiao Zha
Environmental Pollution (2022) Vol. 304, pp. 119175-119175
Closed Access | Times Cited: 9
Inhibitory mechanism of vortioxetine on CYP450 enzymes in human and rat liver microsomes
Yunyun Zhan, Anzhou Wang, Yige Yu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Vortioxetine in management of major depressive disorder – a favorable alternative for elderly patients?
Dorota Danielak
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 9, pp. 1167-1177
Closed Access | Times Cited: 8
Vortioxetine: a comprehensive update on a new-generation antidepressant
Cüneyt Evren
Dusunen Adam The Journal of Psychiatry and Neurological Sciences (2021)
Open Access | Times Cited: 2
Page 1

Scroll to top